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OPEN
ORIGINAL ARTICLE
Pleiotropy between neuroticism and physical and mental
health: ﬁndings from 108038 men and women in UK Biobank
CR Gale1,2,3,9, SP Hagenaars1,2,4,9, G Davies1,2, WD Hill1,2, DCM Liewald1,2, B Cullen5, BW Penninx6, International Consortium for Blood
Pressure GWAS, CHARGE Consortium Aging and Longevity Group, DI Boomsma7, J Pell5, AM McIntosh4, DJ Smith5, IJ Deary1,2,10 and
SE Harris1,8,10
People with higher levels of neuroticism have an increased risk of several types of mental disorder. Higher neuroticism has also
been associated, less consistently, with increased risk of various physical health outcomes. We hypothesised that these associations
may, in part, be due to shared genetic inﬂuences. We tested for pleiotropy between neuroticism and 17 mental and physical
diseases or health traits using linkage disequilibrium regression and polygenic proﬁle scoring. Genetic correlations were derived
between neuroticism scores in 108 038 people in the UK Biobank and health-related measures from 14 large genome-wide
association studies (GWASs). Summary information for the 17 GWASs was used to create polygenic risk scores for the health-related
measures in the UK Biobank participants. Associations between the health-related polygenic scores and neuroticism were
examined using regression, adjusting for age, sex, genotyping batch, genotyping array, assessment centre and population
stratiﬁcation. Genetic correlations were identiﬁed between neuroticism and anorexia nervosa (rg = 0.17), major depressive disorder
(rg = 0.66) and schizophrenia (rg = 0.21). Polygenic risk for several health-related measures were associated with neuroticism, in a
positive direction in the case of bipolar disorder, borderline personality, major depressive disorder, negative affect, neuroticism
(Genetics of Personality Consortium), schizophrenia, coronary artery disease, and smoking (β between 0.009–0.043), and in a
negative direction in the case of body mass index (β=− 0.0095). A high level of pleiotropy exists between neuroticism and
some measures of mental and physical health, particularly major depressive disorder and schizophrenia.
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INTRODUCTION
There is considerable evidence that the personality trait of
neuroticism1—which describes stable individual differences in
the tendency to experience negative emotions—has profound
signiﬁcance for public health.2 People who are higher in neuro-
ticism have an increased risk of developing Axis I psychopathol-
ogy, especially the common mental disorders such as mood,
anxiety, somatoform and substance use disorders, and also
schizophrenia, bipolar disorder and attention-deﬁcit hyperactivity
disorder (ADHD).3–6 Higher neuroticism is associated with
increased likelihood of diagnosis with Axis II personality disorders7
and with greater comorbidity between internalising disorders
(such as major depression, generalised anxiety, panic disorders
and phobias) and externalising disorders (such as alcohol and
drug dependence, antisocial personality and conduct disorders).8
There is evidence that higher neuroticism is linked with risk of
developing Alzheimer’s disease.9 People who are higher in
neuroticism tend to make greater use of mental health services,
regardless of whether they have a mental disorder,10 perhaps
because they are more likely to perceive a need for care.11 The
estimated economic costs of neuroticism in terms of health-care
use and absenteeism are massive.12 Much of these costs relate
to reported chronic somatic conditions.12 Higher neuroticism has
been linked with increased somatic complaints,13,14 with percep-
tion of poorer health,15,16 with future somatic multi-morbidity, as
assessed by a count of reported chronic conditions,17 and with
increased likelihood of reporting a range of physical health
problems.18
Evidence that neuroticism is predictive of objectively assessed
physical health is still relatively sparse and ﬁndings to date are
often mixed. For example, whereas some prospective studies have
found that higher neuroticism increases mortality from all
causes19 or coronary heart disease,20 and is predictive of raised
blood pressure21 or body mass index (BMI),22 others have found
no such association.23–26 In a pooled analysis of data from ﬁve
cohorts, there was no consistent association between neuroticism
and incidence of type 2 diabetes: higher neuroticism was linked
with increased risk in one cohort, but not in others.27
Part of the explanation for associations between neuroticism
and these various mental and physical health outcomes may be
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due to shared genetic inﬂuences. Twin and adoption studies
suggest that genetic inﬂuences account for between a third and a
half of individual differences in neuroticism.1 Many physical and
mental illnesses and health-related measures also show moderate
heritability.28 Twin studies have shown that there is considerable
overlap between the genetic factors that inﬂuence variations in
neuroticism and those that determine risk of depression and other
internalising disorders.29,30 It is now possible to test for such
pleiotropy in associations between neuroticism and health
outcomes using data from single nucleotide polymorphism
(SNP) genotyping in unrelated individuals, making it possible to
carry out much larger studies without the assumptions made by
twin-study methods. A recent genome-wide association meta-
analysis based on data from over 70 000 individuals found that
neuroticism is inﬂuenced by many genetic variants of small effect,
that is, a polygenic effect, that also inﬂuence the risk of major
depressive disorder.31 Whether there is pleiotropy between
neuroticism and other mental disorders or with physical health
outcomes is unclear.
Testing for pleiotropy using SNP-based genetic data can be
carried out in several ways. Linkage disequilibrium (LD) regression
calculates genetic correlations between health measures using the
summary results of genome-wide association studies (GWASs).32 It
determines how much of the genetic inﬂuence on two traits/
diseases is common to both. Polygenic risk scoring33 uses summary
GWAS data for a given illness or health trait to test whether
polygenic liability to that illness/trait is associated with phenotypes
for that illness/trait (for example, neuroticism scores) or others
measured in an independent sample. It allows the amount of
variance in one trait/disease attributed to the polygenic score for a
second trait/disease to be calculated. Polygenic risk of neuroticism
was recently associated with major depressive disorder.31
In the present study we aimed to discover whether shared
genetic aetiology explains part of the associations between
neuroticism and various physical and mental health outcomes,
all of which have been shown to be phenotypically correlated with
neuroticism in at least one study. We used data on over 108 000
UK Biobank participants who completed a questionnaire on
neuroticism and provided DNA for genome-wide genotyping.
Using summary data from GWAS meta-analyses on 17 health-
related measures, we tested for neuroticism-health pleiotropy
using two complementary methods. First, we used LD score
regression to derive genetic correlations between health-related
measures and neuroticism. Second, we calculated the associations
between polygenic risk scores for health-related measures and the
neuroticism phenotype in UK Biobank participants.
MATERIALS AND METHODS
Participants
The participants in this study took part in the baseline survey of UK
Biobank.34 (http://www.ukbiobank.ac.uk). UK Biobank was set up as a
resource for identifying determinants of disease in middle-aged and older
people. Between 2006 and 2010, 502 655 community-dwelling people
aged between 37 and 73 years and living in the United Kingdom were
recruited to the study. They underwent assessments of cognitive and
physical functions, mood and personality. They provided blood, urine and
saliva samples for future analysis, completed questionnaires about their
social backgrounds and lifestyle and agreed to have their health followed
longitudinally. UK Biobank received ethical approval from the Research
Ethics Committee (REC reference 11/NW/0382).
For the present study, genome-wide genotyping data were available on
112 151 individuals (58 914 female) aged 40–73 years (mean age= 56.9
years, s.d. = 7.9) after the quality control process (see below).
Procedures
Neuroticism. Participants completed the Neuroticism scale of the Eysenck
Personality Questionnaire-Revised (EPQ-R) Short Form.35 This scale has
been concurrently validated in older people against two of the most
widely used measures of neuroticism, taken from the International
Personality Item Pool (IPIP) and the NEO-Five Factor Inventory (NEO-FFI);
it correlated − 0.84 with the IPIP-Emotional Stability scale and 0.85 with the
NEO-FFI Neuroticism scale.36 A previous study found a high genetic
correlation (0.91) between the EPQ-R Short Form Neuroticism scale and
psychological distress assessed in a non-psychiatric population using the
30-item General Health Questionnaire.37
Genotyping and quality control. In all, 152 729 UK Biobank blood samples
were genotyped using either the UK BiLEVE38 array (N=49 979) or the UK
Biobank axiom array (N=102 750). A full description of the genotyping
process is available in the Supplementary Materials. Quality control was
performed by Affymetrix (Santa Clara, CA, USA), the Wellcome Trust Centre
for Human Genetics and by the present authors; this included removal of
participants based on missingness, relatedness, gender mismatch, non-
British ancestry and other criteria, and is described in the Supplementary
Materials.
Genome-wide association analyses in the UK Biobank sample. Genome-
wide association analyses were performed on the neuroticism measure in
order to use the summary results for LD regression. Details of the GWAS
procedures are provided in the Supplementary Materials. Results from the
GWAS are published elsewhere.39
Curation of summary results from GWAS consortia on health-related
variables. In order to conduct LD score regression and polygenic proﬁle
score analyses between the UK Biobank neuroticism data and the genetic
predisposition to mental and physical health outcomes, we gathered
summary data from published meta-analyses on 17 health-related
measures: 9 relating to mental health (ADHD, Alzheimer’s disease, anorexia
nervosa, bipolar disorder, borderline personality, major depressive
disorder, negative affect, neuroticism (from the Genetics of Personality
Consortium (GPC)) and schizophrenia) and 8 relating to physical health
(systolic and diastolic blood pressure, BMI, coronary artery disease,
longevity, rheumatoid arthritis, smoking status and type 2 diabetes).
Details of these health-related variables, the consortia’s websites, key
references and number of subjects included in each consortium’s GWAS
are given in Supplementary Table 1.
Statistical analysis
Computing genetic associations between neuroticism and health-related
variables. We use two methods to compute genetic associations between
neuroticism and the health-related variables, LD score regression and
polygenic proﬁle/risk scoring. Each provides a different metric to infer the
existence of pleiotropy between pairs of traits. LD score regression was
used to derive genetic correlations to determine the degree to which the
polygenic architecture of a trait overlaps with that of another. Genetic
correlations were also derived between the different physical and mental
health measures, and neuroticism based on the results of the GWAS from
the GPC by de Moor et al.31 A genetic correlation between the two
neuroticism GWAS (UK Biobank and GPC) was also calculated. The
polygenic risk score method was used to test the extent to which the
polygenic information from GWASs of health-related variables could
predict neuroticism in the UK Biobank participants. Both LD score
regression and polygenic risk scores are dependent on the traits analysed
being highly polygenic in nature, that is, where a large number of variants
of small effect contribute towards phenotypic variation.32,40 LD score
regression was performed between the 14 health-related traits from GWAS
consortia, as some measures did not pass thresholds to be included in LD
score analysis, while the polygenic proﬁle score analyses were performed
on the complete set of 17 health-related traits from GWAS consortia.
LD score regression. In order to quantify the extent of pleiotropy between
neuroticism, measured in UK Biobank, and the collated health traits, we
used LD score regression.32,41 This is a class of techniques that exploits the
correlational structure of the SNPs found across the genome (we provide
more details of LD score regression in the Supplementary Materials). Here
we use LD score regression to derive genetic correlations between
neuroticism and health-related measures using 14 large GWAS consortia
data sets that enable pleiotropy of their health-related traits to be
quantiﬁed with the neuroticism trait in UK Biobank. We followed the data-
processing pipeline devised by Bulik-Sullivan et al.32,41 described in more
detail in the Supplementary Materials. In order to ensure that the genetic
correlation for the Alzheimer’s disease phenotype was not driven by a
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single locus or biased the ﬁt of the regression model, a 500-kb region
centred on the APOE locus was removed and this phenotype was re-run.
This additional model is referred to in Table 1 as ‘Alzheimer’s disease
(500 kb)’.
Polygenic proﬁling. The UK Biobank genotyping data required recoding
from numeric (1, 2) allele coding to standard ACGT format before being
used in polygenic proﬁle scoring analyses. This was achieved using a
bespoke programme developed by one of the present authors (DCML),
details of which are provided in the Supplementary Materials.
Polygenic proﬁles were created for 17 health-related phenotypes
(Table 2 and Supplementary Table 2) in all genotyped participants using
PRSice.42 This software calculates the sum of alleles associated with the
phenotype of interest across many genetic loci, weighted by their effect
sizes estimated from a GWAS of that phenotype in an independent sample.
Before creating the scores, SNPs with a minor allele frequency o0.01 were
removed, and clumping was used to obtain SNPs in linkage equilibrium
with an r2o0.25 within a 200-bp window. Multiple scores were then
created for each phenotype containing SNPs selected according to the
signiﬁcance of their association with the phenotype. The GWAS summary
data for the 12 health-related phenotypes were used to create ﬁve
polygenic proﬁles for each in the UK Biobank participants, at thresholds of
Po0.01, Po0.05, Po0.1, Po0.5 and all SNPs. The most predictive
threshold will be presented in the main tables of this paper. The full results,
including all ﬁve thresholds, can be found in Supplementary Table 2.
Associations between the polygenic proﬁles and neuroticism were
examined in linear regression models, adjusting for age at measurement,
sex, genotyping batch and array, assessment centre and the ﬁrst 10
genetic principal components to adjust for population stratiﬁcation. We
corrected for multiple testing across all polygenic proﬁle scores at all
signiﬁcance thresholds for associations with neuroticism using the false
discovery rate method.43 As neuroticism on average is higher in females
and likely declines with age,2 age- (under and over 60 years old) and
gender-stratiﬁed models were examined.
RESULTS
Within UK Biobank, 108 038 individuals with genotype data
completed the Neuroticism scale of the EPQ-R Short Form. Their
mean (s.d.) score for neuroticism was 4.02 (3.17).
The genetic correlation between neuroticism measured in
the UK Biobank and neuroticism measured in the GPC is 1.0
(s.e. = 0.11).
Table 1 shows the genetic correlations obtained using LD score
regression between neuroticism in UK Biobank and neuroticism
from the GPC, and the published GWAS results on the health-
related traits. Neuroticism in UK Biobank showed signiﬁcant
positive genetic correlations with three traits, all related to mental
health, namely major depressive disorder (rg = 0.66), schizophrenia
(rg = 0.21) and anorexia nervosa (rg = 0.17). The ﬁndings replicated
when using Neuroticism from the GPC. There were no signiﬁcant
genetic correlations between neuroticism and either the other
mental health-related traits (ADHD, Alzheimer’s disease and
bipolar disorder) or any of the physical health-related traits
(systolic and diastolic blood pressure, BMI, coronary artery disease,
type 2 diabetes, smoking status, rheumatoid arthritis or longevity).
These results are shown graphically in Figure 1.
Table 2 shows the results of the polygenic risk scoring, using the
most predictive threshold of the ﬁve that were created. Higher
polygenic risk for six mental health-related traits, bipolar disorder,
borderline personality, major depressive disorder, negative affect,
neuroticism (calculated using summary data from the GPC) and
schizophrenia, was signiﬁcantly associated with higher levels of
neuroticism in UK Biobank (standardised β between 0.017 and
0.043). There were no signiﬁcant associations between neuroti-
cism and polygenic risk for the other mental health-related traits
examined, namely ADHD, Alzheimer’s disease and anorexia
nervosa. Polygenic risk scores for three physical health-related
traits were signiﬁcantly associated with neuroticism: higher
polygenic risk for BMI was associated with lower levels of
neuroticism (β=− 0.0095, P= 0.0015), higher polygenic risk for
coronary artery disease was associated with higher levels of
neuroticism (β= 0.011, P= 0.0003) and higher polygenic proﬁle
scores for smoking were associated with higher levels of
neuroticism (β= 0.17, P= 2.48 × 10− 7). No signiﬁcant associations
were found between polygenic risk for the other physical health-
related traits (systolic and diastolic blood pressure, type 2
diabetes, rheumatoid arthritis or longevity) and neuroticism. To
test whether the false discovery rate signiﬁcant association
between polygenic risk for coronary artery disease and neuroti-
cism was confounded by individuals diagnosed with cardiovas-
cular disease, 2717 individuals who had had a heart attack and
2468 individuals with angina were removed from the regression
analysis. Our estimate of the association between polygenic risk of
coronary artery disease and neuroticism was unchanged by this
exclusion. The same applied for major depressive disorder
(excluding 7494 individuals with a probable diagnosis of major
Table 1. Genetic correlations between neuroticism documented in UK Biobank and mental and physical health-related traits curated from GWAS
consortia
Trait Category Traits from GWAS consortia Neuroticism (UKB) (n= 108 038) Neuroticism (GPC) (n=63 661)
rg s.e. P rg s.e. P
Mental health ADHD 0.060 0.082 0.4681 0.090 0.191 0.6371
Alzheimer’s disease 0.118 0.080 0.1378 0.089 0.177 0.6147
Alzheimer’s disease (500 kb) 0.091 0.063 0.1514 0.051 0.145 0.7262
Anorexia nervosa 0.174 0.04 2.36× 10−5 0.319 0.082 9.56× 10−5
Bipolar disorder 0.083 0.052 0.1096 0.162 0.101 0.1091
Major depressive disorder 0.659 0.087 2.75× 10−14 1.073 0.199 7.15× 10−8
Schizophrenia 0.212 0.050 2.39× 10−5 0.198 0.068 0.0033
Physical health Blood pressure: diastolic − 0.011 0.078 0.887 − 0.108 0.091 0.2363
Blood pressure: systolic − 0.051 0.060 0.3959 –0.008 0.083 0.925
BMI − 0.036 0.028 0.1921 0.046 0.055 0.4077
Coronary artery disease 0.104 0.053 0.0489 0.221 0.104 0.0331
Longevity − 0.083 0.081 0.3011 0.002 0.163 0.9888
Rheumatoid arthritis − 0.0816 0.05 0.103 − 0.093 0.123 0.4463
Smoking status 0.113 0.05 0.0205 0.124 0.090 0.1657
Type 2 diabetes − 0.145 0.07 0.0389 0.044 0.107 0.6837
Abbreviations: ADHD, attention-deﬁcit hyperactivity disorder; BMI, body mass index; GPC, Genetics of Personality Consortium; GWAS, genome-wide
association study; UKB, UK Biobank. Statistically signiﬁcant P-values (after false discovery rate correction—Po0.0033) are shown in bold.
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depression or bipolar disorder44), where the estimate of the
association showed little change. The complete polygenic risk
score results, including all ﬁve thresholds, are shown in
Supplementary Table 2.
Age- and gender-stratiﬁed analyses indicated there were no
substantial differences by age or gender for 13 out of 17 traits.
Four traits did show a potential age or gender effect. Polygenic
risk for anorexia nervosa predicts neuroticism in males, but not in
females. Polygenic risk for diastolic blood pressure predicts
neuroticism only in females over 60 years of age. The strongest
associations between polygenic risk for negative affect and
smoking status, and neuroticism, are in females under 60 years
of age. The full results for these stratiﬁed analyses can be found in
Supplementary Table 3.
DISCUSSION
In this study of 108 038 men and women from UK Biobank who
had been genotyped and assessed for neuroticism, we exploited
the summary results of 17 large international GWAS consortia to
Table 2. Associations between polygenic risk scores for mental and physical health-related traits created from GWAS consortia summary data and
neuroticism in UK Biobank participants, adjusted for age, sex, assessment centre, genotyping batch and array, and 10 principal components for
population stratiﬁcation
Trait category Traits from GWAS consortia Neuroticism (n= 108 038)
Threshold β R2 P
Mental health ADHD 0.05 0.0045 2.06× 10− 5 0.1292
Alzheimer’s disease 0.05 − 0.0065 4.16× 10− 5 0.0312
Anorexia nervosa 0.1 0.0054 2.87× 10− 5 0.0735
Bipolar disorder 0.5 0.0171 0.0003 1.71× 10−8
Borderline personality 1 0.0150 0.0002 5.43× 10−7
Major depressive disorder 1 0.0357 0.0012 1.23× 10−31
Negative affect (anxiety) 1 0.00949 8.99× 10− 5 1.55× 10−3
Neuroticism (GPC) 0.5 0.0433 0.0020 1.77× 10−47
Schizophrenia 0.1 0.0359 0.0012 7.88× 10−32
Physical health Blood pressure: diastolic 0.1 − 0.0047 2.20× 10− 5 0.1167
Blood pressure: systolic 0.05 − 0.0016 2.51× 10− 6 0.5969
BMI 0.01 − 0.0095 9.00× 10− 5 0.0015
Coronary artery disease 0.1 0.0109 0.00012 0.0003
Longevity 0.05 − 0.0051 2.55× 10− 5 0.0917
Rheumatoid arthritis 0.5 − 0.0007 5.09× 10− 5 0.8266
Smoking status 0.5 0.0167 0.0002 2.48× 10−7
Type 2 diabetes 0.01 − 0.0031 9.67× 10−6 0.2989
Abbreviations: ADHD, attention-deﬁcit hyperactivity disorder; BMI, body mass index; GPC, Genetics of Personality Consortium; GWAS, genome-wide
association study. The associations between the polygenic risk scores and neuroticism with the largest effect size (threshold) are presented. Statistically
signiﬁcant P-values (after false discovery rate correction—Po0.0065) are shown in bold.
Figure 1. Barplot of genetic correlations (s.e.) calculated using linkage disequilibrium score regression between neuroticism in UK Biobank
(UKB) and the Genetics of Personality Consortium (GPC), and mental and physical health measures from genome-wide association study
consortia. *Po0.0033. ADHD, attention-deﬁcit hyperactivity disorder; BMI, body mass index.
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examine whether there is pleiotropy between neuroticism and a
range of physical and mental health outcomes using two
methods, LD score regression and polygenic proﬁle scoring.
Summary results from two separate GWASs of neuroticism
showed a genetic correlation of 1.0. Using summary data from
both of these studies of neuroticism, the genetic correlations that
were calculated with physical and mental health were very similar.
As regards the six mental health outcomes that were investigated
using both LD score regression and polygenic proﬁle scoring, we
found consistent evidence of pleiotropy between neuroticism and
both major depression and schizophrenia with these methods,
showing that, to a signiﬁcant degree, the same genetic variants
are responsible for the heritability of each pair of phenotypes and
that genetic variants associated with major depression or
schizophrenia in GWAS consortia are signiﬁcantly predictive of
variation in neuroticism in UK Biobank. There was some evidence
for pleiotropy between neuroticism, and bipolar disorder, border-
line personality, anorexia nervosa and negative affect on the basis
of results from polygenic proﬁle scoring or LD score regression,
respectively, but the extent of these associations varied according
to the method used. In all cases where there was a signiﬁcant
ﬁnding using one method but not the other, the direction of effect
was the same using both methods. We found no evidence of
pleiotropy between neuroticism and the other mental health
outcomes examined—ADHD and Alzheimer’s disease. Of the eight
physical health outcomes studied, none showed evidence of
pleiotropy with neuroticism on the basis of the genetic correla-
tions obtained from LD score regression, but there was some
indication of genetic overlap between neuroticism and coronary
artery disease, smoking status and BMI. Higher polygenic risk for
coronary artery disease and smoking status was signiﬁcantly
associated with higher levels of neuroticism, and polygenic risk for
higher BMI was associated with lower levels of neuroticism.
No associations were found between polygenic risk for the
other physical health-related traits (systolic and diastolic blood
pressure, rheumatoid arthritis, type 2 diabetes or longevity) and
neuroticism.
Previous investigations into pleiotropy between neuroticism
and mental health outcomes using polygenic risk proﬁling have
found evidence of substantial shared genetic aetiology between
neuroticism and major depression.31,45,46 Our observations in the
present, much larger, sample conﬁrm those ﬁndings and for, we
believe, the ﬁrst time quantify the extent to which the same
genetic variants are responsible for the heritability in these two
phenotypes, using an additional metric, LD score regression.32 The
relatively high genetic correlation between neuroticism and major
depression (rg = 0.66), identiﬁed in our study, is similar to the
genetic correlation identiﬁed in a previous twin study (rg = 0.43).
30
Our results also provide the ﬁrst evidence, to our knowledge, that
the phenotypic correlations found between neuroticism and
schizophrenia47,48 are due at least in part to genetic overlap.
The extent of pleiotropy between anorexia nervosa or bipolar
disorder and neuroticism has been unclear, though there is some,
though limited, evidence to link both disorders phenotypically
with neuroticism.5,49 A previous study found no signiﬁcant
association between polygenic risk scores for neuroticism and
bipolar disorder, but the sample size was small.46 In this much
larger sample, higher polygenic risk scores for bipolar disorder
were signiﬁcantly predictive of higher neuroticism, but results of
LD score regression showed little indication of genetic correlation
between neuroticism and this disorder. We found a small but
highly signiﬁcant genetic correlation between neuroticism and
anorexia (rg = 0.17), but there was no association between
polygenic risk scores for this condition and neuroticism. Although
there is now considerable evidence that neuroticism is a risk factor
for the development of Alzheimer’s disease,9 there was no
indication in our analyses that shared genes account for this link.
So far as we are aware, there have been no previous
investigations of the extent of pleiotropy between neuroticism
and physical health outcomes. This may be because, whereas
there is considerable evidence for phenotypic associations
between higher neuroticism and poorer self-rated health or
greater somatic complaints,13–18 fewer studies have examined
neuroticism as a predictor of objectively measured physical health
outcomes, and ﬁndings on such outcomes as coronary heart
disease, blood pressure, BMI and all-cause mortality have been
inconsistent.19–26 Of the eight objectively measured physical
health outcomes included in the current study, three showed
evidence of a degree of genetic pleiotropy with neuroticism:
coronary artery disease, smoking status and BMI. Neither
demonstrated any measurable genetic correlation with neuroti-
cism, but higher polygenic risk score for coronary artery disease
was associated with higher neuroticism. This is consistent with the
ﬁnding in pooled data from three cohorts that higher neuroticism
was associated with increased mortality from coronary heart
disease.20 Higher polygenic risk for BMI was associated with lower
neuroticism. The direction of this association was unexpected.
Findings on the phenotypic relationships between neuroticism
and BMI have produced inconsistent results: one study showed
higher neuroticism was associated with higher BMI,22 but another
found no association.25
The chief strength of our study is the large sample size that
permits powerful, robust tests of genetic association. Second, all
the UK Biobank genetic data were processed at the same location
and on the same platform. Finally, use of summary data from 17
large international GWAS consortia studies allowed us to perform
a comprehensive examination of the degree of pleiotropy
between neuroticism and a range of physical and mental
health-related phenotypes, and to produce many of the ﬁrst
estimates of the genetic correlation between neuroticism and
these phenotypes.
Our study also has some limitations. First, the GWAS studies we
curated to carry out LD score regression and extract polygenic risk
scores often involved meta-analyses of results from data sets with
considerable heterogeneity in sample size, genome-wide imputa-
tion quality and measurement of phenotypes. With larger and
more consistent independent data sets, it should be possible to
use the polygenic risk scores to predict more variance in
neuroticism. Second, we restricted the genotyped samples to
individuals of white British ancestry in order to minimise any
inﬂuence of population structure. Our results therefore need to be
replicated in large samples with different genetic backgrounds as
we did not have the power to model data from UK Biobank
individuals of other ancestries. In the stratiﬁed analysis 13 out of
17 traits did not indicate a gender or age effect. These stratiﬁed
results need to be interpreted with caution; they were mostly null,
and no multiple testing correction was applied due to the high
correlations between the different models. The four traits that did
indicate potential gender or age effects need to be replicated in
an independent sample, before any conclusions can be drawn
from them.
We note that genetic correlations reﬂect the amount of the
genetic inﬂuence on two traits that is common to both. This is
independent of the heritability of either trait. Therefore, it is
entirely possible for a trait to have a small proportion of variance
accounted for by genetic variants, but to have a high genetic
correlation with another trait. The amount of variance explained
by each polygenic proﬁle score is small, as would be expected by
the fact that not all SNPs were genotyped, and those that were do
not necessarily accurately tag the causal genetic variants. The
polygenic risk score most predictive threshold varied between
health traits, suggesting that the amount of shared genetic
aetiology between neuroticism and each of the health traits
differs. Although testing multiple thresholds may be deemed to
increase the multiple testing problem, it should be noted that the
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SNPs included in each threshold are not independent. Also, at
least for major depressive disorder and schizophrenia, pleiotropy
was quantiﬁed using LD score regression, which involved only a
single test per pair of phenotypes. The estimate of neuroticism
variance explained by each polygenic proﬁle should be consid-
ered as the minimum estimate of the variance explained. Owing
to pruning SNPs in LD, the polygenic risk score method makes the
assumption of a single causal variant being tagged in each LD
block considered. If this assumption is not true for the phenotypes
considered, the proportion of variance explained will be
underestimated here.
In this large sample from UK Biobank, we aimed to discover
whether shared genetic aetiology explained part of the associa-
tions between neuroticism and various physical and mental health
outcomes. Our ﬁndings suggest that associations between
neuroticism and several mental health outcomes including major
depression, schizophrenia, bipolar disorder and anorexia nervosa
are in part due to shared genetic inﬂuences. We found that
polygenic risk scores for coronary artery disease, smoking and BMI
were predictive of neuroticism scores. This large-scale mapping of
the extent of pleiotropy between neuroticism and physical and
mental health outcomes adds to our understanding of the cause
of links between this important personality trait and later health.
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